Supporting Innovative Food Products
Under the Food and Drugs Act and Regulations, all foods that have been produced through new processes, that do not have a history of safe use as a food, or that have been modified by genetic manipulation are considered novel foods and must be assessed by Health Canada before they can be sold in Canada.
Characterizing a product as novel or innovative can be tricky, as can be the process for completing the required federal assessment. KGK Science’s Canada-based regulatory team, led by the author of the Draft New Dietary Ingredient Guidance and former Branch Chief of Toxicology at the FDA, is uniquely equipped to support your business in securing the required evidence for completing a successful novel foods application.
- Technical review and GAP analysis to ensure that evidence will meet requirements
- Planning studies to support identity and safety data requirements including protocol development, study management, and analysis of results
- Expert regulatory toxicologists writing your application and corresponding directly with Health Canada to ensure requirements are met and the process is completed.
Regulatory Consulting Expertise
Led by a former FDA Regulator, KGK’s seasoned regulatory experts are uniquely equipped to provide an insider’s perspective into regulatory operations and the most effective way to navigate a timely and compliant path-to-market. Backed by a vast network of scientific, legal, and regulatory professionals, you’ll receive dedicated support throughout each step of the process.
Leading Clinical Research Since 1997
Clinical Trials Across 40+ Indications
Data Points Collected
Years In Business
Full Time Employees
Supporting Your Business with High-Quality Expertise
As a premium full-service contract research organization, KGK Science provides clinical trial research and regulatory services that meet the highest quality standards, customized to meet the needs of our clients. Contact us today and stake your claim.